SCHEMBL14713858

SCHEMBL14713858

Cc1nn(COCC[Si](C)(C)C)c2cnc(-c3cccnc3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.41
PIM1 P11309 12/20 0.41
PIM3 Q86V86 3/20 0.41
PIM2 Q9P1W9 3/20 0.41
DGAT1 O75907 1/20 0.39
MAPT P10636 1/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2E1 P05181 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2B6 P20813 2/20 0.37
CYP2C19 P33261 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PDE6D O43924 1/20 0.35
PDE5A O76074 1/20 0.35
PDE6A P16499 1/20 0.35
PDE6G P18545 1/20 0.35
PDE6B P35913 1/20 0.35
PDE6C P51160 1/20 0.35
PDE6H Q13956 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14688761 0.89 DGAT1 (0.40) CYP2A6PIM1PIM3PIM2DGAT1
SCHEMBL14689121 0.87 DGAT1 (0.38) CYP2A6PIM1PIM3PIM2DGAT1
SCHEMBL14688516 0.86 PIM1 (0.49) CYP2A6PIM1PIM3PIM2DGAT1
SCHEMBL14688835 0.84 PIM1 (0.52) CYP2A6PIM1PIM3PIM2DGAT1
SCHEMBL14713862 0.83 PIM1 (0.46) CYP2A6PIM1PIM3PIM2DGAT1
SCHEMBL14688870 0.83 PIM1 (0.53) PIM1PIM3PIM2DGAT1MAPT
SCHEMBL14689482 0.82 PIM1 (0.50) PIM1PIM3PIM2DGAT1MAPT
SCHEMBL14689076 0.82 PIM1 (0.38) CYP2A6PIM1PIM3PIM2DGAT1
SCHEMBL14689125 0.82 PIM1 (0.41) PIM1PIM3PIM2DGAT1
SCHEMBL14688648 0.81 PIM1 (0.43) CYP2A6PIM1PIM3PIM2DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013024002-A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2013-02-21 WO disclosed